Pregled bibliografske jedinice broj: 998609
Centrally transported botulinum toxin type A relieves local spastic paralysis
Centrally transported botulinum toxin type A relieves local spastic paralysis // International Conference of the International Neurotoxin Association (INA) Toxins 2019
Kopenhagen, Danska, 2019. str. S78-S78 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 998609 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Centrally transported botulinum toxin type A relieves local spastic paralysis
Autori
Matak, Ivica ; Lacković, Zdravko ; Relja, Maja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
International Conference of the International Neurotoxin Association (INA) Toxins 2019
Mjesto i datum
Kopenhagen, Danska, 16.01.2019. - 19.01.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Axonal transport ; Botulinum toxin type A ; Local spastic paralysis ; Tetanus toxin ; Transcytosis ; Ventral horn
Sažetak
Introduction: Injections of botulinum neurotoxin type A (BoNT/A) provide an essential treatment for muscle hyperactivity disorders such as spasticity and dystonias. Recently discovered BoNT/A enzymatic action in motor regions of the central nervous system (CNS) indicate the possible involvement of central action in its therapeutic effect. Centrally transported BoNT/A was shown to be a prerequisite to its antinociceptive activity, while up to now, the functional role of BoNT/A axonal transport in the motor nervous system has been unknown. Here, we studied the central effect of BoNT/A in experimental focal muscular hyperactivity evoked by tetanus toxin (TeNT). Methods: Localized muscle rigidity was induced by low-dose intramuscular (IM) TeNT into rat gastrocnemius (1 to 1.5 ng). Pharmacologic response to intramuscular and intrasciatic injection of BoNT/A (5 U/kg) and intraperitoneal R(+) baclofen (3 mg/kg) was assessed by different motor parameters and tests. BoNT/A transcytosis in the CNS was investigated by intrathecal BoNT/A antitoxin and cleaved synaptosomal-associated protein 25 (SNAP-25) immunohistochemistry. Results: TeNT injected into the calf muscle induced local spastic paralysis. Intramuscular and intrasciatic BoNT/A and baclofen reduced TeNT-evoked hind-paw extension and ankle flexion resistance, while intrasciatic BoNT/A improved rotarod performance. Intrasciatic BoNT/A led to accumulation of toxin enzymatic activity in the CNS without any paralytic effect in normal animals. The effect of intrasciatic BoNT/A on local spasticity and the occurrence of cleaved SNAP-25 in the ventral horn were prevented by intrathecal antitoxin, indicating that the toxin is transcytosed by extracellular movement into second-order synapses. Conclusion: Central effects of BoNT/A do not measurably affect normal motor function ; however, in our experiments, they eliminated local spastic paralysis induced by TeNT. Present results suggest that the central effects of BoNT/A might account for clinically observed improvements of muscle function in spastic conditions and dystonias that are not concurrent with local muscle paralysis
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Scopus
- MEDLINE